The following table presents information about the performance of the Company’s reportable segments for the three and nine months ended September 30, 2026 and 2025:


	Americas		EMEA		Asia/Pacific		Totals
Three Months Ended September 30, 2026
Net sales (1)	$	254,030	$	152,466	$	138,052	$	544,548
Significant segment expenses
Product costs (2)	131,937		82,986		75,351		290,274
Other segment items (3)	56,436		38,306		27,646		122,388
Segment operating earnings	$	65,657	$	31,174	$	35,055	$	131,886

Nine Months Ended September 30, 2026
Net sales (1)	$	704,271	$	452,985	$	400,321	$	1,557,577
Significant segment expenses
Product costs (2)	358,894		240,525		212,857		812,276
Other segment items (3)	168,532		122,985		81,574		373,091
Segment operating earnings	$	176,845	$	89,475	$	105,890	$	372,210


	Americas		EMEA		Asia/Pacific		Totals
Three Months Ended September 30, 2025
Net sales (1)	$	222,787	$	143,900	$	127,155	$	493,842
Significant segment expenses
Product costs (2) (5)	111,097		77,544		65,646		254,287
Other segment items (3)	52,777		39,877		25,940		118,594
Segment operating earnings	$	58,913	$	26,479	$	35,569	$	120,961

Nine Months Ended September 30, 2025
Net sales (1)	$	657,560	$	413,101	$	349,495	$	1,420,156
Significant segment expenses
Product costs (2) (4) (5)	325,102		222,385		186,475		733,962
Other segment items (3)	156,107		115,849		72,806		344,762
Segment operating earnings	$	176,351	$	74,867	$	90,214	$	341,432

(2) Product costs include the costs of raw materials and are recorded in Cost of goods sold in the Company’s Condensed Consolidated Statements of Operations.

(3) Other segment items include overhead costs of operating the Company’s production facilities and providing chemical management services to customers and direct SG&A costs.

(4) Product costs includes the $6.0 million amortization of the fair value step-up in Dipsol's inventories as a result of the acquisition during the nine months ended September 30, 2025, which is comprised of approximately $2.6 million in the Americas segment, $3.0 million in the Asia/Pacific segment, and $0.4 million in the EMEA segment.

(5) Product costs includes a $0.7 million loss and a $2.9 million gain related to immaterial out-of-period adjustments for inventory for the three and nine months ended September 30, 2025, respectively. The $0.7 million loss was recognized in the Americas segment during the three months ended September 30, 2025. The $2.9 million gain recognized during the nine months ended September 30, 2025 was comprised of a $0.7 million gain in the Americas segment and $2.2 million gain in the EMEA segment.

The following table presents a reconciliation of the Company’s segment operating earnings to income (loss) before taxes and equity in net income of associated companies in the Company’s Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Segment operating earnings	$	131,886	$	120,961	$	372,210	$	341,432
Restructuring and related charges, net	(8,263)		(7,745)		(23,760)		(31,128)
Impairment charges	—		—		—		(88,840)
Non-operating and administrative expenses	(57,262)		(49,560)		(172,552)		(151,137)
Depreciation of corporate assets and amortization	(17,508)		(17,015)		(52,853)		(48,572)
Operating income	48,853		46,641		123,045		21,755
Other expense, net	(797)		(270)		(414)		(1,632)
Interest expense	(10,023)		(10,941)		(29,775)		(33,265)
Income (loss) before taxes and equity in net income of associated companies	$	38,033	$	35,430	$	92,856	$	(13,142)